StocksMedium•5 November 2026•
1 min read
IPCA Laboratories Q2 Profit Jumps 32.5% on Strong Export Performance
Key Facts
1IPCA Laboratories reported a 32.5% year-on-year increase in consolidated net profit to ₹375 crore for the second quarter.
2Revenue from operations grew 13.8% to ₹2,910 crore, supported by a 17% rise in export income.
3EBITDA margins expanded to 23% from 21% in the previous year.
IPCA Laboratories reported a 32.5% year-on-year increase in consolidated net profit to ₹375 crore for the second quarter ending September 2026. IndiaIPO reported that revenue from operations grew 13.8% to ₹2,910 crore, supported by a 17% rise in export income.
The company's EBITDA margins expanded to 23% from 21% in the previous year. Shares of IPCA Laboratories saw a minor decline during trading on November 5, 2026, as the company disclosed legal provisions related to its subsidiary, Unichem Laboratories, in the United Kingdom.